Senior Scientist (m/f/d), Computational Pathology Biomarker Lead (BioPharmaceuticals)

ABOUT ASTRAZENECA

AstraZeneca is a global, science-led, patient-focused biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines for some of the world's most serious diseases. But we're more than one of the world's leading pharmaceutical companies.

SITE DESCRIPTION - Munich, Germany

At Computational Pathology Munich (CPM), we make a significant contribution to high-performance, data-driven research and development. Our team operates in a demanding, fast-paced environment where excellent collaboration, clear communication and precise organization are critical.

BUSINESS AREA
AstraZeneca's Enterprise AI organization is building the future of drug development by connecting data, technology, and expertise to accelerate breakthroughs across our portfolio.

Within Computational Pathology and Biomarkers, we develop AI-powered solutions to advance patient selection, biomarker development, and clinical decision-making at scale. We work collaboratively across the organization to translate innovation into tangible impact across BioPharma, including CVRM, Respiratory & Immunology, and Rare Diseases.